Biomarin Pharmaceutical Inc (BMRN)
Operating return on assets (Operating ROA)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 615,495 | 776,080 | 619,645 | 484,214 | 337,026 | 253,658 | 198,772 | 172,714 | 133,995 | 101,053 | 74,639 | 149,562 | 108,182 | 57,380 | 29,900 | -82,341 | -61,301 | -64,023 | -116,640 | -36,765 |
| Total assets | US$ in thousands | 7,614,870 | 7,456,340 | 7,147,010 | 6,988,940 | 6,851,200 | 7,067,120 | 6,872,670 | 6,841,600 | 6,758,160 | 6,563,170 | 6,433,700 | 6,375,070 | 6,264,040 | 6,145,840 | 6,062,710 | 6,003,320 | 5,977,480 | 5,898,500 | 5,805,050 | 5,848,020 |
| Operating ROA | 8.08% | 10.41% | 8.67% | 6.93% | 4.92% | 3.59% | 2.89% | 2.52% | 1.98% | 1.54% | 1.16% | 2.35% | 1.73% | 0.93% | 0.49% | -1.37% | -1.03% | -1.09% | -2.01% | -0.63% |
September 30, 2025 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $615,495K ÷ $7,614,870K
= 8.08%
Peer comparison
Sep 30, 2025
Company name
Symbol
Operating ROA
Biomarin Pharmaceutical Inc
BMRN
8.08%
Arrowhead Pharmaceuticals Inc
ARWR
7.10%
Regeneron Pharmaceuticals Inc
REGN
9.18%